Reid Robison is a Director and Chief Medical Officer at Novamind, in addition to being the Co-founder of Cedar Psychiatry. He is also a founding board member at the Utah-based non-profit Psychedelic Institute. Dr. Robison serves as Coordinating Investigator of the MAPS (Multidisciplinary Association for Psychedelic Studies) MDMA-Assisted Psychotherapy study of Eating Disorders, supervising the training and clinical research of all of the MDMA therapy sites. Additionally, he works in a medical and therapeutic capacity at psychedelic medicine retreats abroad, and often consults on medical safety issues and plant medicine use.
Reid was born in Chicago, but grew up in Toronto, Canada. He completed undergraduate studies in Neuroscience at Brigham Young University, and went on to medical school at the University of Utah where he earned both his MD and MBA degrees. After residency training in Psychiatry at the University of Utah, Dr. Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics. He currently serves as adjunct faculty at both the University of Utah and Brigham Young University.